60 Degrees Pharmaceuticals, Inc.
SXTP
$2.93
-$0.08-2.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.32% | 48.24% | -1,069.29% | 121.39% | -148.10% |
| Total Depreciation and Amortization | 8.16% | 33.64% | -50.23% | -5.56% | -7.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -76.38% | -73.55% | 270.99% | -361.04% | 111.30% |
| Change in Net Operating Assets | 182.92% | -219.35% | 1,240.61% | -98.74% | 151.72% |
| Cash from Operations | 2.56% | -41.49% | -4.19% | -1,690.27% | 98.30% |
| Capital Expenditure | 100.00% | 84.67% | -- | -- | -3,000.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 99.88% | -4,168.23% | -314.29% | 9.26% | 58.62% |
| Cash from Investing | 99.88% | -1,237.37% | -1,232.65% | 85.29% | -138.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | 104,504.00% | -99.74% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 227.63% | -1,255.93% | 63.58% | -110.77% | 3,956.41% |
| Cash from Financing | -99.98% | 572,344.44% | -100.05% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -211.11% | 20.00% | 287.50% | -101.48% | 482.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.20% | 230.80% | -275.23% | 1,088.44% | -103.46% |